Published in AIDS Weekly, February 22nd, 1999
The opening of this Phase I trial, sponsored by the U.S. National Institute of Allergy and Infectious Diseases (NIAID), "is an important step in an attempt to develop HIV vaccines for countries hardest hit by the AIDS pandemic," commented Anthony S. Fauci, MD, NIAID.
The Ugandan Minister of Health, Crispus Kiyonga, MBChB, added, "This trial is part of a long-term, joint program that began in 1991 with our U.S. and French partners to develop a safe and effective HIV vaccine for Africa. Broad consultations have taken place and consensus has been reached among...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.